Position in NBIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,439,861
-$56,843,067 QoQ
Shares Held
44,143
-91.0% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#178
of 768 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Derivatives in NBIX
reported options exposure · as of Dec 31, 2024CallValue
$0
CallShares
0
PutValue
$586,950
PutShares
4,300
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Squarepoint Ops LLC holds $151,394,819 across 40 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
633,370 | $45,513,968 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
48,656 | $26,363,280 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
|
617,308 | $21,402,068 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
140,059 | $8,956,773 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
This page
|
44,143 | $7,439,861 | |
| 6 | ALKS |
Alkermes plc.
|
115,195 | $6,036,218 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
133,225 | $3,278,667 | |
| 8 | HROW |
Harrow, Inc.
|
73,622 | $3,126,726 |
All Filings in NBIX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,439,861 | 44,143 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $64,282,928 | 487,953 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $29,742,601 | 209,706 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $5,682,722 | 40,481 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $20,940,205 | 166,602 | Shares | Defined | 2025-08-27 | |
| 2024-12-31 | $586,950 | 4,300 | Put | Defined | 2025-02-14 | |
| 2024-09-30 | $7,877,476 | 68,369 | Shares | Defined | 2024-11-14 | |
| 2024-03-31 | $4,248,763 | 30,806 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $10,564,648 | 80,181 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,189,487 | 28,351 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $11,127,117 | 117,997 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $16,785,919 | 165,836 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $4,003,867 | 33,522 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $6,124,068 | 57,660 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,267,629 | 13,004 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $9,135,375 | 97,444 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,292,804 | 62,144 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,677,178 | 17,487 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,872,436 | 19,240 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $276,870 | 2,847 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $387,617 | 4,044 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,330,758 | 13,839 | Shares | Defined | 2020-11-16 | |
| 2020-03-31 | $2,740,173 | 31,660 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||